{"id":"placebo-first-then-oradur","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Constipation"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Sedation"},{"rate":"5-10%","effect":"Withdrawal symptoms"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"ORADUR works by releasing buprenorphine slowly over time, providing long-lasting pain relief. Buprenorphine is a partial opioid agonist that binds to opioid receptors in the brain, reducing the perception of pain.","oneSentence":"ORADUR is a sustained-release formulation of buprenorphine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:59.179Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe pain"}]},"trialDetails":[{"nctId":"NCT02450890","phase":"PHASE3","title":"Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD","status":"COMPLETED","sponsor":"Orient Pharma Co., Ltd.","startDate":"2015-06","conditions":"Attention Deficit Hyperactivity Disorder","enrollment":114}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Placebo"],"phase":"phase_3","status":"active","brandName":"Placebo First, then ORADUR®","genericName":"Placebo First, then ORADUR®","companyName":"Orient Pharma Co., Ltd.","companyId":"orient-pharma-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"ORADUR is a sustained-release formulation of buprenorphine. Used for Moderate to severe pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}